ATE521591T1 - 11c-markierte benzyl-lactam-verbindungen und deren verwendung als bildgebungsmittel - Google Patents
11c-markierte benzyl-lactam-verbindungen und deren verwendung als bildgebungsmittelInfo
- Publication number
- ATE521591T1 ATE521591T1 AT06701554T AT06701554T ATE521591T1 AT E521591 T1 ATE521591 T1 AT E521591T1 AT 06701554 T AT06701554 T AT 06701554T AT 06701554 T AT06701554 T AT 06701554T AT E521591 T1 ATE521591 T1 AT E521591T1
- Authority
- AT
- Austria
- Prior art keywords
- labled
- benzyl
- imaging agents
- lactam compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64345305P | 2005-01-13 | 2005-01-13 | |
| PCT/IB2006/000028 WO2006075226A1 (en) | 2005-01-13 | 2006-01-11 | 11c-labeled benzyl-lactam compounds and their use as imaging agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE521591T1 true ATE521591T1 (de) | 2011-09-15 |
Family
ID=36061190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06701554T ATE521591T1 (de) | 2005-01-13 | 2006-01-11 | 11c-markierte benzyl-lactam-verbindungen und deren verwendung als bildgebungsmittel |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8012969B2 (de) |
| EP (1) | EP1836164B1 (de) |
| AT (1) | ATE521591T1 (de) |
| ES (1) | ES2371927T3 (de) |
| WO (1) | WO2006075226A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007026224A2 (en) * | 2005-08-31 | 2007-03-08 | Pfizer Products Inc. | 5-ht1b antagonist composition for depression, anxiety and cognition |
| JP5820887B2 (ja) | 2010-11-10 | 2015-11-24 | ハー・ルンドベック・アクチエゼルスカベット | 放射性標識されたフェニルイミダゾールベースのリガンド |
| CN110590634A (zh) * | 2019-09-29 | 2019-12-20 | 迈奇化学股份有限公司 | 一种1-乙酰基-2-吡咯烷酮的生产方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6462048B2 (en) | 1996-03-29 | 2002-10-08 | Pfizer Inc. | Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-HT1A- and/or 5-HT1D receptors |
| EP1113015B1 (de) | 1999-12-29 | 2004-09-15 | Pfizer Products Inc. | Optisch aktive 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone als selektive 5-HT1D Rezeptor Antagonisten |
| CN1934081A (zh) * | 2004-03-17 | 2007-03-21 | 辉瑞产品公司 | 新型(亚)苄基－内酰胺衍生物 |
-
2006
- 2006-01-11 EP EP06701554A patent/EP1836164B1/de not_active Not-in-force
- 2006-01-11 US US11/813,779 patent/US8012969B2/en not_active Expired - Fee Related
- 2006-01-11 ES ES06701554T patent/ES2371927T3/es active Active
- 2006-01-11 WO PCT/IB2006/000028 patent/WO2006075226A1/en active Application Filing
- 2006-01-11 AT AT06701554T patent/ATE521591T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US8012969B2 (en) | 2011-09-06 |
| US20080206137A1 (en) | 2008-08-28 |
| EP1836164A1 (de) | 2007-09-26 |
| EP1836164B1 (de) | 2011-08-24 |
| WO2006075226A1 (en) | 2006-07-20 |
| ES2371927T3 (es) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201100301A1 (ru) | Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения | |
| BRPI0507684B8 (pt) | agentes de contraste para imagem de perfusão miocárdica | |
| CY1113011T1 (el) | Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην | |
| BRPI0606318A2 (pt) | composto, composição, e, uso de um composto | |
| IL181529A (en) | A method for radiofluorination, a compound containing radioactive fluorine and its use in the preparation of a radioactive drug | |
| CO6280399A2 (es) | Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i | |
| ATE547944T1 (de) | Desinfizierende zusammensetzungen enthaltend glycerin-monoalkylethern und bis- pyridiniumalkanen und deren verwendung als hautantiseptika | |
| EA201001680A1 (ru) | Соединения бензолсульфонамидтиазола и оксазола | |
| BRPI0607455A2 (pt) | composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica | |
| CY1110425T1 (el) | Συνεργεια των gos και της πολυφρουκτοζης | |
| CY1115262T1 (el) | Ανταγωνιστες trpv1 και χρησεις αυτων | |
| PE20120007A1 (es) | Sintesis de estirilpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de estas | |
| BRPI0813341A2 (pt) | " uso de compostos, composições curáveis, e, uso de composições curáveis ". | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| EA200800974A1 (ru) | Композиции с улучшенной биодоступностью, содержащие стероидное производное и полигликолизированный глицерид | |
| EA201170703A1 (ru) | Производные адамантилбензамида | |
| CR11245A (es) | Mejoras en compuestos organicos o relacionadas con los mismos | |
| BRPI0714885B8 (pt) | compostos terapêuticos e seu uso | |
| BR112012014737A2 (pt) | calconas como realçador de agentes antimicrobianos | |
| NZ606466A (en) | Peptide radiotracer compositions | |
| CY1115094T1 (el) | Νεα μεθοδος για την συνθεση (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στην συνθεση αγομελατινης | |
| WO2010000409A3 (en) | Compounds and processes for production of radiopharmaceuticals | |
| NO20084821L (no) | Formuleringer og metoder for celleimaging og terapi | |
| DE602005006157D1 (de) | STABILISIERTE 99mTC ZUSAMMENSETZUNG | |
| DE602006008639D1 (de) | Automatisches radioaktives markierungsverafhren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |